日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Chemotherapy for biliary tract cancer: real-world experience in a single institute

胆道癌化疗：单一机构的真实世界经验

期刊:Nagoya Journal of Medical Science
影响因子:0.9
doi:10.18999/nagjms.82.4.725
Maeda, Osamu; Ebata, Tomoki; Shimokata, Tomoya; Matsuoka, Ayumu; Inada-Inoue, Megumi; Morita, Sachi; Takano, Yuko; Urakawa, Hiroshi; Miyai, Yuki; Sugishita, Mihoko; Mitsuma, Ayako; Ando, Masahiko; Mizuno, Takashi; Nagino, Masato; Ando, Yuichi
肿瘤
胆管癌
肿瘤免疫
发表日期：2020
文献求助 收藏

FOLFIRINOX-induced reversible dysarthria: A case report and review of previous cases

FOLFIRINOX 诱发的可逆性构音障碍：病例报告及既往病例回顾

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2015.3591
Matsuoka, Ayumu; Maeda, Osamu; Inada-Inoue, Megumi; Ohno, Eizaburo; Hirooka, Yoshiki; Yokoyama, Yukihiro; Fujii, Tsutomu; Nagino, Masato; Goto, Hidemi; Ando, Yuichi
发表日期：2015
文献求助 收藏

Phase I dose-escalation study of buparlisib (BKM120), an oral pan-class I PI3K inhibitor, in Japanese patients with advanced solid tumors

一项针对日本晚期实体瘤患者的口服泛I类PI3K抑制剂buparlisib（BKM120）的I期剂量递增研究

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.12350
Ando, Yuichi; Inada-Inoue, Megumi; Mitsuma, Ayako; Yoshino, Takayuki; Ohtsu, Atsushi; Suenaga, Naoko; Sato, Masahiko; Kakizume, Tomoyuki; Robson, Matthew; Quadt, Cornelia; Doi, Toshihiko
发表日期：2014
文献求助 收藏